USPTO
US PTAB Invalidates 10x Genomics Single-Cell Patent
An inter partes review, filed by competitor Parse Biosciences, nullified one of three patents 10x alleged infringement of in a 2022 lawsuit against Parse.
Geneoscopy Challenges Exact Sciences Patent Through Inter Partes Review Petition
The company argued that the sample preparation and fecal tests cited in Exact's patent are not inventive and represent routine, well-established methods.
US Appeals Court Reverses Patent Office Decision That Blocked Snipr Biome CRISPR IP
The appeals court found that the US Patent Trial and Appeal Board had erred in subjecting Snipr's patents to an interference, which was eliminated under a recent patent law change.
USPTO Rules in Favor of Broad Institute in CRISPR/Cas9 IP Dispute
The Broad's CRISPR/Cas9 patents were found to have priority over similar IP from the University of California and others.
Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable
This week, the US PTAB found that some claims of a Personal Genomics patent for single-molecule detection didn't hold up, while others remain valid.